Montreal, Canada

Aimesther Betancourt

USPTO Granted Patents = 8 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2013-2024

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Aimesther Betancourt: Innovator in Pharmaceutical Compositions

Introduction

Aimesther Betancourt is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions and methods for treating disorders related to muscarinic receptor activation. With a total of eight patents to her name, her work is recognized for its innovative approach to drug formulation.

Latest Patents

Among her latest patents is a groundbreaking oral pharmaceutical composition that includes a plurality of xanomeline beads, which contain xanomeline or a salt thereof. Additionally, the composition features a plurality of trospium beads, which have a core comprising a salt of trospium. This innovative formulation aims to enhance the treatment of disorders ameliorated by muscarinic receptor activation.

Career Highlights

Aimesther has worked with notable companies in the pharmaceutical industry, including Karuna Therapeutics, Inc. and Laurent Pharmaceuticals. Her experience in these organizations has allowed her to refine her expertise and contribute to the advancement of medical treatments.

Collaborations

Throughout her career, Aimesther has collaborated with esteemed colleagues such as Roch Thibert and Bruce Rehlaender. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Aimesther Betancourt's contributions to pharmaceutical innovations are noteworthy, and her patents reflect her commitment to improving treatment options for various disorders. Her work continues to inspire future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…